Lung Cancer Treatment "Alone"? You are out.

The current status of lung cancer treatment

Early stage lung cancer is mainly treated by surgery (for those who refuse surgery due to physical condition, chronic disease, age, etc., stereotactic radiotherapy is feasible); intermediate stage and locally advanced stage is mainly treated by surgery, radiotherapy and chemotherapy; and advanced stage is mainly treated by internal medicine such as chemotherapy, targeting and immunotherapy.

Surgery can be used throughout the treatment process of lung cancer;

Precise and targeted radiotherapy and intensity-modulated radiotherapy are involved in 75% of lung cancer patients;

Internal medicine has entered a new era of targeted immunotherapy;

Minimally invasive treatments, such as particle implantation, radiofrequency ablation, and interventional therapy, as a recurrence of the disease after surgery and radiotherapy, have provided new treatment choices for lung cancer patients;

The treatment of lung cancer patients has also become the mainstay of medical treatment, including chemotherapy, radiotherapy, radiotherapy, radiotherapy, and immunotherapy.

Cancer pain and nutritional support therapy also improve the quality of life and maintain the dignity of patients.

What kind of situation needs MDT

Lung tumors need MDT in the whole process from consultation to diagnosis, from diagnostic pathology, staging to treatment, but not all patients need it, so what kind of situation needs it?

The first type: lung space is found in the CT examination due to physical discomfort or physical examination, at this time, is it benign or malignant? The pathology is not clear, and the diagnostic staging is not certain, then it is necessary to organize the MDT discussion, to take the appropriate means of examination to clarify the diagnosis, and to improve the accuracy of the staging, which will help to reduce the unnecessary diagnosis and treatment.

The second type: For patients with clear pathology and staging diagnosis of lung cancer, MDT is conducive to the adoption of the best individualized treatment plan in the initial treatment or multiple treatments, and the MDT discussion can enable more early and middle and late stage lung cancer patients to receive multidisciplinary comprehensive treatment; it is conducive to the treatment according to the guideline and evidence-based medicine; it is conducive to the development of individualized treatment plan with the patient in mind; and it is conducive to the patient-centered treatment plan. It is also conducive to the development of patient-centered and individualized treatment plans, as well as to the improvement of doctors' clinical diagnosis and treatment ability and scientific research ability.

MDT work form

For first-time patients, difficult and critical patients, and patients with unclear diagnosis of lung cancer, MDT consultation will be carried out in a timely manner to clarify the diagnosis and formulate an individualized treatment plan;

For patients who are difficult, have complex conditions, or need to consult famous experts, we will promptly invite domestic famous experts to carry out remote MDT via the Internet, which will help to improve the clinical diagnosis and treatment ability and scientific research ability.

How to register?

Patients should bring their chest CT films and related examination and laboratory materials to the hospital, first apply for a consultation card, and then go to the third floor of the outpatient clinic to make a request for a consultation, and then the doctor of the outpatient clinic will contact the MDT expert group for a consultation.

For patients who need to be seen by a specialist from a higher level hospital, they should first go through the admission procedure, and then the doctor in the ward will be responsible for contacting the specialist from the higher level hospital for remote consultation.

Lung Cancer MDT Clinic

Clinic No. 1, 6, 9, 10 on the third floor of the outpatient building

Outpatient Time

Every Monday to Saturday

Contact Phone:

Head Expert

Chen

Xingxiu

Director of Oncology Ward 2, Deputy Chief Physician